- Home
- OTLK vs CNTY Comparison
OTLK vs CNTY Comparison
Compare OTLK & CNTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OTLK | CNTY |
|---|---|---|
| Founded | 2010 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.7M | 45.1M |
| IPO Year | 2016 | 1996 |
Fundamental Metrics
Financial Performance| Metric | OTLK | CNTY |
|---|---|---|
| Price | $0.44 | $1.50 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $3.83 | $3.67 |
| AVG Volume (30 Days) | ★ 1.2M | 28.4K |
| Earning Date | 06-02-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.91 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $8,146,123.00 | ★ $430,529,000.00 |
| Revenue This Year | $1,726.70 | $2.20 |
| Revenue Next Year | $80.34 | $7.18 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 10.82 |
| 52 Week Low | $0.38 | $1.23 |
| 52 Week High | $3.39 | $2.85 |
Technical Indicators
Market Signals| Indicator | OTLK | CNTY |
|---|---|---|
| Relative Strength Index (RSI) | 43.21 | 43.46 |
| Support Level | $0.39 | $1.48 |
| Resistance Level | $0.46 | $1.56 |
| Average True Range (ATR) | 0.03 | 0.07 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 68.45 | 29.03 |
Price Performance
Historical ComparisonAbout OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA, which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About CNTY Century Casinos Inc.
Century Casinos Inc is a casino entertainment company that develops and operates gaming establishments as well as related lodging, restaurants, horse racing (including off-track betting), and entertainment facilities in North America. The company has three reportable segments based on the geographical locations in which its casinos operate; United States; Century Casino & Hotel-Central City, and Century Casino & Hotel-Cripple Creek in Colorado, Mountaineer Casino, Racetrack & Resort in West Virginia, and Century Casino Caruthersville, and Century Casino Cape Girardeau in Missouri, Canada; Century Casino & Hotel, Century Casino St. Albert, Century Mile Racetrack in Edmonton and Casino Century Downs Racetrack and Casino in Calgary, and Poland; Casinos Poland.